Title: CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's
disease
Version: 3 Date: 21 Apr 2022
Reviewer:  Ilhami Yuksel
Reviewer's report:
Congratulations to the authors for editing all but one of the proposals.
The Authors evaluated severity and extent of inflammatory lesions using CDEIS and active
disease was defined as CDEIS #3, which was addressed in the endoscopic data collection section.
In the predictors of disease activity and severity in CTE section; The Authors addressed that
to determine CT findings, endoscopic lesion (of any type) or ulcers at endoscopy or CDEIS #3
was used. If the active disease was defined as CDEIS #3, it should be used in the Table 3, or if
the Authors will use non-ulcerative lesions or ulceration as endoscopic activity parameters, they
should defined that clearly in the endoscopic data collection section instead of CDEIS #3.
This study is acceptable for publication after arrangement of recommendation.
Title: CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's
disease
Version: 3 Date: 21 Apr 2022
Reviewer:  Ilhami Yuksel
Reviewer's report:
Congratulations to the authors for editing all but one of the proposals.
The Authors evaluated severity and extent of inflammatory lesions using CDEIS and active
disease was defined as CDEIS #3, which was addressed in the endoscopic data collection section.
In the predictors of disease activity and severity in CTE section; The Authors addressed that
to determine CT findings, endoscopic lesion (of any type) or ulcers at endoscopy or CDEIS #3
was used. If the active disease was defined as CDEIS #3, it should be used in the Table 3, or if
the Authors will use non-ulcerative lesions or ulceration as endoscopic activity parameters, they
should defined that clearly in the endoscopic data collection section instead of CDEIS #3.
This study is acceptable for publication after arrangement of recommendation.
Please review this paper.
user
Title: CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's
disease
Version: 3 Date: 21 Apr 2022
Reviewer:  Ilhami Yuksel
Reviewer's report:
Congratulations to the authors for editing all but one of the proposals.
The Authors evaluated severity and extent of inflammatory lesions using CDEIS and active
disease was defined as CDEIS #3, which was addressed in the endoscopic data collection section.
In the predictors of disease activity and severity in CTE section; The Authors addressed that
to determine CT findings, endoscopic lesion (of any type) or ulcers at endoscopy or CDEIS #3
was used. If the active disease was defined as CDEIS #3, it should be used in the Table 3, or if
the Authors will use non-ulcerative lesions or ulceration as endoscopic activity parameters, they
should defined that clearly in the endoscopic data collection section instead of CDEIS #3.
This study is acceptable for publication after arrangement of recommendation.
assistant